i contacted the Company to find out when Vraylar would be out in Australia...this is what they said.
Cariprazine was developed by Gedeon Richter for the treatment of schizophrenia and bipolar maniac disorder and was launched in the US in March 2016 as Vraylar®. Cariprazine is currently available only in the US, however, the European Medicines Agency (EMA) is currently evaluating our marketing authorization application of Cariprazine. Hopefully the product will be available in the European Union soon and then Cariprazine can be rolled out in other countries, too.
For anyone who might be interested.